Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MoonLake Immunotherapeutics | MLTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 51.72 | 04:11:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 51.72 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 9.08 - 63.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 51.72 | USD |
MoonLake Immunotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.23B | 62.45M | - | 0 | -64.51M | -1.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MoonLake Immunotherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MLTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.51 | 54.58 | 42.51 | 48.77 | 957,286 | 9.21 | 21.67% |
| 1 Month | 40.17 | 54.58 | 35.53 | 43.79 | 714,036 | 11.55 | 28.75% |
| 3 Months | 56.09 | 63.25 | 35.11 | 48.07 | 720,389 | -4.37 | -7.79% |
| 6 Months | 27.95 | 63.40 | 24.31 | 49.26 | 731,820 | 23.77 | 85.04% |
| 1 Year | 9.30 | 63.40 | 9.08 | 42.16 | 497,778 | 42.42 | 456.13% |
| 3 Years | 12.37 | 63.40 | 4.25 | 38.41 | 331,883 | 39.35 | 318.11% |
| 5 Years | 12.37 | 63.40 | 4.25 | 38.41 | 331,883 | 39.35 | 318.11% |
MoonLake Immunotherapeut... Description
| MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. |
